Gemmer Asset Management LLC United Therapeutics Corp Transaction History

Gemmer Asset Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 22, 2022	SELL	$174.81 - $241.14 $19,054 - $26,284	-109 Closed	0 $0
Q3 2020 Oct 21, 2020	BUY	$99.9 - $121.13 $299 - $363	3 Added 2.83%	109 $11,000
Q2 2020 Jul 31, 2020	BUY	$92.74 - $125.82 $1,576 - $2,138	17 Added 19.1%	106 $13,000
Q3 2019 Oct 11, 2019	SELL	$74.85 - $85.99 $3,293 - $3,783	-44 Reduced 33.08%	89 $7,000
Q2 2019 Jul 18, 2019	BUY	$76.06 - $120.81 $1,825 - $2,899	24 Added 22.02%	133 $10,000

Q1 2019 Apr 17, 2019	BUY	$107.15 - $126.84 $107 - $126	1 Added 0.93%	109 $13,000
Q1 2018 May 11, 2018	SELL	$107.21 - $151.94 $964 - $1,367	-9 Reduced 7.69%	108 $12,000
Q3 2017 Oct 12, 2017	BUY	$114.6 - $136.81 $13,408 - $16,006	117	117 $14,000

567

43.6M

501K

529K

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $15B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

Get notified when there are updates to the investment portfolio of Gemmer Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Gemmer Asset Management LLC with notifications on news.